Environmental considerations in human genomic data governance: overcoming normative challenges.

backgroundHuman genomics involves generating, processing, storing, using and sharing immense amounts of information. This will only increase given efforts to embed whole genome sequencing into mainstream clinical practice. However, as society becomes more conscious about the impact of human activity on the environment, it is imperative to consider what this means for the future of genomic data generation and its governance.

methodsThere is scant literature on environmental ethics in the context of genomic data governance. To address this gap, we drew on existing debates and scholarship relating to the environmental impact of biobanking, healthcare generally, and data-intensive healthcare specifically, to construct the strongest conceptual challenges to the proposal that environmental concerns should be incorporated into genomic data governance frameworks. Each challenge was critically examined.

resultsWe developed five conceptual obstacles to incorporating environmental considerations in genomic data governance: genomic data optimism; the outcome measurement challenge; the responsibility challenge; the worse offender challenge; and technological idealism. We argue that no objection, when considered individually or together, provides strong enough reasons to ignore or de-prioritise environmental considerations in genomic data governance. We suggest three proposals to move forward with environmental ethics in genomic data governance: research ethics committees should pilot how to consider environmental ethics when assessing and approving genomic research; environmental considerations should be explicitly considered in all prospective genomic data generation; the sector should catalogue low-value practices that can be easily discontinued with minimal disruption.

conclusionAs a rapidly growing field, the environmental harm from genomic data generation is certain and significant. The relevant question, then, is not whether but how to mitigate the harms without compromising genomics’ potential benefits.